The Kaplan–Meier analyses demonstrated that expression of Iba1 or CD163 negatively correlated to GBM patient survival (Fig. 1i,j and Supplementary Fig. 1j,k), suggesting that higher TAM infiltration contributes to more aggressive GBMs. Here, CD163 is linked to glioblastoma.